焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?

Psychiatria Spersonalizowana Pub Date : 2023-01-01 DOI:10.5114/psychs.2023.125705

Sławomir Murawiec, Natalia Olejnik, Agata Kudlik

{"title":"焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?","authors":"Sławomir Murawiec, Natalia Olejnik, Agata Kudlik","doi":"10.5114/psychs.2023.125705","DOIUrl":null,"url":null,"abstract":"AMA Murawiec S, Olejnik N, Kudlik A. Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana. 2023;2(1):7-15. doi:10.5114/psychs.2023.125705. APA Murawiec, S., Olejnik, N., & Kudlik, A. (2023). Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana, 2(1), 7-15. https://doi.org/10.5114/psychs.2023.125705 Chicago Murawiec, Sławomir, Natalia Olejnik, and Agata Kudlik. 2023. \"Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?\". Psychiatria Spersonalizowana 2 (1): 7-15. doi:10.5114/psychs.2023.125705. Harvard Murawiec, S., Olejnik, N., and Kudlik, A. (2023). Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana, 2(1), pp.7-15. https://doi.org/10.5114/psychs.2023.125705 MLA Murawiec, Sławomir et al. \"Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?.\" Psychiatria Spersonalizowana, vol. 2, no. 1, 2023, pp. 7-15. doi:10.5114/psychs.2023.125705. Vancouver Murawiec S, Olejnik N, Kudlik A. Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana. 2023;2(1):7-15. doi:10.5114/psychs.2023.125705.","PeriodicalId":500880,"journal":{"name":"Psychiatria Spersonalizowana","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?\",\"authors\":\"Sławomir Murawiec, Natalia Olejnik, Agata Kudlik\",\"doi\":\"10.5114/psychs.2023.125705\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"AMA Murawiec S, Olejnik N, Kudlik A. Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana. 2023;2(1):7-15. doi:10.5114/psychs.2023.125705. APA Murawiec, S., Olejnik, N., & Kudlik, A. (2023). Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana, 2(1), 7-15. https://doi.org/10.5114/psychs.2023.125705 Chicago Murawiec, Sławomir, Natalia Olejnik, and Agata Kudlik. 2023. \\\"Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?\\\". Psychiatria Spersonalizowana 2 (1): 7-15. doi:10.5114/psychs.2023.125705. Harvard Murawiec, S., Olejnik, N., and Kudlik, A. (2023). Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana, 2(1), pp.7-15. https://doi.org/10.5114/psychs.2023.125705 MLA Murawiec, Sławomir et al. \\\"Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?.\\\" Psychiatria Spersonalizowana, vol. 2, no. 1, 2023, pp. 7-15. doi:10.5114/psychs.2023.125705. Vancouver Murawiec S, Olejnik N, Kudlik A. Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana. 2023;2(1):7-15. doi:10.5114/psychs.2023.125705.\",\"PeriodicalId\":500880,\"journal\":{\"name\":\"Psychiatria Spersonalizowana\",\"volume\":\"11 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychiatria Spersonalizowana\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/psychs.2023.125705\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatria Spersonalizowana","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/psychs.2023.125705","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

A.焦虑障碍的药物治疗:波兰精神科医生宣布哪些物质是首选治疗方案?精神病学杂志，2009;2(1):7-15。doi: 10.5114 / psychs.2023.125705。APA Murawiec, S, Olejnik, N， & Kudlik, A.(2023)。焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?精神病学杂志，2(1)，7-15。https://doi.org/10.5114/psychs.2023.125705 Chicago Murawiec, Sławomir, Natalia Olejnik和Agata Kudlik。2023。焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?精神病学杂志2(1):7-15。doi: 10.5114 / psychs.2023.125705。Harvard Murawiec, S, Olejnik, N.和Kudlik, A.(2023)。焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?精神病学杂志，2(1)，pp.7-15。https://doi.org/10.5114/psychs.2023.125705 MLA Murawiec, Sławomir等。焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?精神病学，第二卷，第2期。1, 2023，第7-15页。doi: 10.5114 / psychs.2023.125705。王晓明，王晓明。焦虑障碍的药物治疗:波兰精神病学家宣布哪些药物是首选治疗方案?精神病学杂志，2009;2(1):7-15。doi: 10.5114 / psychs.2023.125705。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?

AMA Murawiec S, Olejnik N, Kudlik A. Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana. 2023;2(1):7-15. doi:10.5114/psychs.2023.125705. APA Murawiec, S., Olejnik, N., & Kudlik, A. (2023). Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana, 2(1), 7-15. https://doi.org/10.5114/psychs.2023.125705 Chicago Murawiec, Sławomir, Natalia Olejnik, and Agata Kudlik. 2023. "Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?". Psychiatria Spersonalizowana 2 (1): 7-15. doi:10.5114/psychs.2023.125705. Harvard Murawiec, S., Olejnik, N., and Kudlik, A. (2023). Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana, 2(1), pp.7-15. https://doi.org/10.5114/psychs.2023.125705 MLA Murawiec, Sławomir et al. "Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?." Psychiatria Spersonalizowana, vol. 2, no. 1, 2023, pp. 7-15. doi:10.5114/psychs.2023.125705. Vancouver Murawiec S, Olejnik N, Kudlik A. Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana. 2023;2(1):7-15. doi:10.5114/psychs.2023.125705.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Psychiatria Spersonalizowana

自引率

0.00%

发文量